Truepoint, Inc. Merck & Co., Inc. Transaction History

Truepoint, Inc.

$3.65 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$100.18 - $109.02 $141,053 - $153,500	1,408 Added 21.02%	8,106 $883,000
Q3 2023 Nov 09, 2023	BUY	$102.95 - $114.33 $132,805 - $147,485	1,290 Added 23.85%	6,698 $689,000
Q2 2023 Aug 08, 2023	BUY	$108.61 - $118.38 $2,823 - $3,077	26 Added 0.48%	5,408 $624,000
Q1 2023 May 08, 2023	BUY	$102.94 - $114.86 $720 - $804	7 Added 0.13%	5,382 $572,000
Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $1,923 - $2,466	-22 Reduced 0.41%	5,375 $596,000
Q3 2022 Nov 14, 2022	SELL	$84.53 - $94.96 $37,700 - $42,352	-446 Reduced 7.63%	5,397 $465,000
Q2 2022 Aug 08, 2022	SELL	$83.49 - $94.64 $13,775 - $15,615	-165 Reduced 2.75%	5,843 $533,000
Q1 2022 May 11, 2022	BUY	$73.51 - $82.4 $661 - $741	9 Added 0.15%	6,008 $493,000
Q4 2021 Feb 02, 2022	BUY	$72.28 - $90.54 $130,826 - $163,877	1,810 Added 43.21%	5,999 $460,000
Q3 2021 Oct 28, 2021	SELL	$71.68 - $78.83 $33,402 - $36,734	-466 Reduced 10.01%	4,189 $315,000
Q2 2021 Aug 04, 2021	BUY	$70.31 - $77.77 $53,294 - $58,949	758 Added 19.45%	4,655 $362,000
Q1 2021 Apr 30, 2021	BUY	$68.86 - $81.11 $482 - $567	7 Added 0.18%	3,897 $300,000
Q4 2020 Feb 02, 2021	BUY	$71.77 - $79.65 $279,185 - $309,838	3,890 New	3,890 $318,000
Q1 2020 May 13, 2020	SELL	$63.36 - $87.82 $288,921 - $400,459	-4,560 Closed	0 $0
Q4 2019 Jan 27, 2020	BUY	$77.58 - $87.54 $12,024 - $13,568	155 Added 3.52%	4,560 $415,000
Q3 2019 Nov 07, 2019	BUY	$76.08 - $82.93 $456 - $497	6 Added 0.14%	4,405 $371,000
Q2 2019 Aug 08, 2019	SELL	$69.84 - $81.59 $102,175 - $119,366	-1,463 Reduced 24.96%	4,399 $369,000
Q1 2019 May 15, 2019	BUY	$69.58 - $79.36 $80,225 - $91,502	1,153 Added 24.49%	5,862 $488,000
Q4 2018 Feb 13, 2019	SELL	$65.24 - $75.71 $93,749 - $108,795	-1,437 Reduced 23.38%	4,709 $360,000
Q3 2018 Nov 14, 2018	SELL	$57.69 - $67.84 $117,283 - $137,918	-2,033 Reduced 24.86%	6,146 $436,000
Q2 2018 Aug 09, 2018	BUY	$50.83 - $59.72 $393,627 - $462,471	7,744 Added 1780.23%	8,179 $496,000
Q1 2018 May 08, 2018	SELL	$50.96 - $59.23 $241,295 - $280,454	-4,735 Reduced 91.59%	435 $7.99 Million
Q4 2017 Feb 05, 2018	BUY	$51.62 - $61.64 $63,544 - $75,878	1,231 Added 31.25%	5,170 $291,000
Q3 2017 Nov 21, 2017	SELL	$58.67 - $63.13 $14.6 Million - $15.7 Million	-248,285 Reduced 98.44%	3,939 $252,000
Q3 2017 Nov 17, 2017	BUY	$58.67 - $63.13 $14.8 Million - $15.9 Million	252,224	252,224 $252,000

Others Institutions Holding MRK

# of Institutions

3,824

Shares Held

1.88B

Call Options Held

15.6M

Put Options Held

13.7M

Vanguard Group Inc Valley Forge, PA

250M
Shares

$25.8 Billion
0.52% of portfolio
Black Rock Inc. New York, NY

207M
Shares

$21.4 Billion
0.59% of portfolio
State Street Corp Boston, MA

119M
Shares

$12.3 Billion
0.56% of portfolio
Wellington Management Group LLP Boston, MA

75.8M
Shares

$7.82 Billion
1.55% of portfolio
Geode Capital Management, LLC Boston, MA

59.2M
Shares

$6.1 Billion
0.55% of portfolio

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $261B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Truepoint, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Truepoint, Inc. with notifications on news.

Account